Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Lim

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 20, 2018
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative ReviewShazli Azmi, Kariem T ElHadd, Andrew Nelson, et al.
Neuroendocrinology|October 23, 2019
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine NeoplasmsKok Haw Jonathan Lim, Hussain Raja, Paolo D'Arienzo, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
Real-world data from first UK Omnipod 5 users: A single-centre observational studyAisha Aslam, Alyson Chapman, Andrea Urwin, et al.
ESMO Open|March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanomaKok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.
European Journal of Cancer Care|December 22, 2020
Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centresJoachim Chan, Helen Adderley, Manal Alameddine, et al.
Cancer|May 12, 2025
The BEV1L study: Do real-world outcomes associated with the addition of bevacizumab to first-line chemotherapy in patients with ovarian cancer reinforce clinical trial findings?Linda R Duska, Jonathan Lim, Tirza Areli Calderón Boyle, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, et al.
BMJ Open|February 16, 2020
Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trialDimitris Papamargaritis, Werd Al-Najim, Jonathan Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 7, 2024
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, et al.
Hepatology Communications|September 22, 2025
Psychosocial therapy improves outcomes for alcohol use disorder in people with chronic liver disease: A systematic review and meta-analysisChristopher H Sollenberger, Huai-En R Chang, Jonathan Lim, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 20, 2018
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative ReviewShazli Azmi, Kariem T ElHadd, Andrew Nelson, et al.
Neuroendocrinology|October 23, 2019
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine NeoplasmsKok Haw Jonathan Lim, Hussain Raja, Paolo D'Arienzo, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
Real-world data from first UK Omnipod 5 users: A single-centre observational studyAisha Aslam, Alyson Chapman, Andrea Urwin, et al.
ESMO Open|March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanomaKok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.
European Journal of Cancer Care|December 22, 2020
Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centresJoachim Chan, Helen Adderley, Manal Alameddine, et al.
Cancer|May 12, 2025
The BEV1L study: Do real-world outcomes associated with the addition of bevacizumab to first-line chemotherapy in patients with ovarian cancer reinforce clinical trial findings?Linda R Duska, Jonathan Lim, Tirza Areli Calderón Boyle, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, et al.
BMJ Open|February 16, 2020
Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trialDimitris Papamargaritis, Werd Al-Najim, Jonathan Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 7, 2024
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, et al.
Hepatology Communications|September 22, 2025
Psychosocial therapy improves outcomes for alcohol use disorder in people with chronic liver disease: A systematic review and meta-analysisChristopher H Sollenberger, Huai-En R Chang, Jonathan Lim, et al.
Pageof 10